Changes in Serum Natriuretic Peptide Levels after Percutaneous Closure of Small to Moderate Ventricular Septal Defects

Background. B-type natriuretic peptide has been shown to be a very sensitive and specific marker of heart failure. In this study, we aimed to investigate the effect of percutaneous closure of ventricular septal defects with Amplatzer septal occluders on brain natriuretic peptide levels. Methods. Bet...

Full description

Saved in:
Bibliographic Details
Main Authors: Yuksel Kaya, Ramazan Akdemir, Huseyin Gunduz, Sani Murat, Orhan Bulut, İbrahim Kocayigit, M. Bulent Vatan, M. Akif Cakar, Ekrem Yeter, Harun Kilic, Mustafa Tarik Agac, Zeydin Acar
Format: Article
Language:English
Published: Wiley 2012-01-01
Series:The Scientific World Journal
Online Access:http://dx.doi.org/10.1100/2012/328697
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832556962296889344
author Yuksel Kaya
Ramazan Akdemir
Huseyin Gunduz
Sani Murat
Orhan Bulut
İbrahim Kocayigit
M. Bulent Vatan
M. Akif Cakar
Ekrem Yeter
Harun Kilic
Mustafa Tarik Agac
Zeydin Acar
author_facet Yuksel Kaya
Ramazan Akdemir
Huseyin Gunduz
Sani Murat
Orhan Bulut
İbrahim Kocayigit
M. Bulent Vatan
M. Akif Cakar
Ekrem Yeter
Harun Kilic
Mustafa Tarik Agac
Zeydin Acar
author_sort Yuksel Kaya
collection DOAJ
description Background. B-type natriuretic peptide has been shown to be a very sensitive and specific marker of heart failure. In this study, we aimed to investigate the effect of percutaneous closure of ventricular septal defects with Amplatzer septal occluders on brain natriuretic peptide levels. Methods. Between 2008 and 2011, 23 patients underwent successfully percutaneous ventricular septal defect closure in 4 cardiology centers. Brain natriuretic peptide levels were measured in nine patients (4 male, mean ages were 25.3±14.3) who underwent percutaneous closure with Amplatzer occluders for membranous or muscular ventricular septal defects were enrolled in the study. Brain natriuretic peptide levels were measured one day before and one month after the closure. Patients were evaluated clinically and by echocardiography one month after the procedure. Results. Percutaneous closures of ventricular septal defects were successfully performed in all patients. There was not any significant adverse event in patients group during followup. Decrease in brain natriuretic peptide levels after closure were statistically significant (97.3±78.6 versus 26.8±15.6, 𝑃=0.013). Conclusion. Brain Natriuretic Peptide levels are elevated in patients with ventricular septal defects as compared to controls. Percutaneous closure of Ventricular Septal Defect with Amplatzer occluders decreases the BNP levels.
format Article
id doaj-art-8a5ce2682f314978855f308d0f45d705
institution Kabale University
issn 1537-744X
language English
publishDate 2012-01-01
publisher Wiley
record_format Article
series The Scientific World Journal
spelling doaj-art-8a5ce2682f314978855f308d0f45d7052025-02-03T05:43:57ZengWileyThe Scientific World Journal1537-744X2012-01-01201210.1100/2012/328697328697Changes in Serum Natriuretic Peptide Levels after Percutaneous Closure of Small to Moderate Ventricular Septal DefectsYuksel Kaya0Ramazan Akdemir1Huseyin Gunduz2Sani Murat3Orhan Bulut4İbrahim Kocayigit5M. Bulent Vatan6M. Akif Cakar7Ekrem Yeter8Harun Kilic9Mustafa Tarik Agac10Zeydin Acar11Department of Cardiology, Van Yüksek Ihtisas Hospital, 65200 Van, TurkeyDepartment of Cardiology, Faculty of Medicine, Sakarya University, Esentepe, 54054 Sakarya, TurkeyDepartment of Cardiology, Faculty of Medicine, Sakarya University, Esentepe, 54054 Sakarya, TurkeyDepartment of Cardiology, Research and Education Hospital, Dıskapi/Etlik Ihtisas, 06110 Ankara, TurkeyDepartment of Cardiology, Van Yüksek Ihtisas Hospital, 65200 Van, TurkeyDepartment of Cardiology, Faculty of Medicine, Sakarya University, Esentepe, 54054 Sakarya, TurkeyDepartment of Cardiology, Faculty of Medicine, Sakarya University, Esentepe, 54054 Sakarya, TurkeyDepartment of Cardiology, Faculty of Medicine, Sakarya University, Esentepe, 54054 Sakarya, TurkeyDepartment of Cardiology, Research and Education Hospital, Dıskapi/Etlik Ihtisas, 06110 Ankara, TurkeyDepartment of Cardiology, Research and Education Hospital, Dıskapi/Etlik Ihtisas, 06110 Ankara, TurkeyDepartment of Cardiology, Ahi Evren Heart and Vascular Surgery Training and Research Hospital, 61040 Trabzon, TurkeyDepartment of Cardiology, Ahi Evren Heart and Vascular Surgery Training and Research Hospital, 61040 Trabzon, TurkeyBackground. B-type natriuretic peptide has been shown to be a very sensitive and specific marker of heart failure. In this study, we aimed to investigate the effect of percutaneous closure of ventricular septal defects with Amplatzer septal occluders on brain natriuretic peptide levels. Methods. Between 2008 and 2011, 23 patients underwent successfully percutaneous ventricular septal defect closure in 4 cardiology centers. Brain natriuretic peptide levels were measured in nine patients (4 male, mean ages were 25.3±14.3) who underwent percutaneous closure with Amplatzer occluders for membranous or muscular ventricular septal defects were enrolled in the study. Brain natriuretic peptide levels were measured one day before and one month after the closure. Patients were evaluated clinically and by echocardiography one month after the procedure. Results. Percutaneous closures of ventricular septal defects were successfully performed in all patients. There was not any significant adverse event in patients group during followup. Decrease in brain natriuretic peptide levels after closure were statistically significant (97.3±78.6 versus 26.8±15.6, 𝑃=0.013). Conclusion. Brain Natriuretic Peptide levels are elevated in patients with ventricular septal defects as compared to controls. Percutaneous closure of Ventricular Septal Defect with Amplatzer occluders decreases the BNP levels.http://dx.doi.org/10.1100/2012/328697
spellingShingle Yuksel Kaya
Ramazan Akdemir
Huseyin Gunduz
Sani Murat
Orhan Bulut
İbrahim Kocayigit
M. Bulent Vatan
M. Akif Cakar
Ekrem Yeter
Harun Kilic
Mustafa Tarik Agac
Zeydin Acar
Changes in Serum Natriuretic Peptide Levels after Percutaneous Closure of Small to Moderate Ventricular Septal Defects
The Scientific World Journal
title Changes in Serum Natriuretic Peptide Levels after Percutaneous Closure of Small to Moderate Ventricular Septal Defects
title_full Changes in Serum Natriuretic Peptide Levels after Percutaneous Closure of Small to Moderate Ventricular Septal Defects
title_fullStr Changes in Serum Natriuretic Peptide Levels after Percutaneous Closure of Small to Moderate Ventricular Septal Defects
title_full_unstemmed Changes in Serum Natriuretic Peptide Levels after Percutaneous Closure of Small to Moderate Ventricular Septal Defects
title_short Changes in Serum Natriuretic Peptide Levels after Percutaneous Closure of Small to Moderate Ventricular Septal Defects
title_sort changes in serum natriuretic peptide levels after percutaneous closure of small to moderate ventricular septal defects
url http://dx.doi.org/10.1100/2012/328697
work_keys_str_mv AT yukselkaya changesinserumnatriureticpeptidelevelsafterpercutaneousclosureofsmalltomoderateventricularseptaldefects
AT ramazanakdemir changesinserumnatriureticpeptidelevelsafterpercutaneousclosureofsmalltomoderateventricularseptaldefects
AT huseyingunduz changesinserumnatriureticpeptidelevelsafterpercutaneousclosureofsmalltomoderateventricularseptaldefects
AT sanimurat changesinserumnatriureticpeptidelevelsafterpercutaneousclosureofsmalltomoderateventricularseptaldefects
AT orhanbulut changesinserumnatriureticpeptidelevelsafterpercutaneousclosureofsmalltomoderateventricularseptaldefects
AT ibrahimkocayigit changesinserumnatriureticpeptidelevelsafterpercutaneousclosureofsmalltomoderateventricularseptaldefects
AT mbulentvatan changesinserumnatriureticpeptidelevelsafterpercutaneousclosureofsmalltomoderateventricularseptaldefects
AT makifcakar changesinserumnatriureticpeptidelevelsafterpercutaneousclosureofsmalltomoderateventricularseptaldefects
AT ekremyeter changesinserumnatriureticpeptidelevelsafterpercutaneousclosureofsmalltomoderateventricularseptaldefects
AT harunkilic changesinserumnatriureticpeptidelevelsafterpercutaneousclosureofsmalltomoderateventricularseptaldefects
AT mustafatarikagac changesinserumnatriureticpeptidelevelsafterpercutaneousclosureofsmalltomoderateventricularseptaldefects
AT zeydinacar changesinserumnatriureticpeptidelevelsafterpercutaneousclosureofsmalltomoderateventricularseptaldefects